Tenet Healthcare selloff overdone

Tenet Q4 Earnings Beat Estimates on Favorable Payer Mix
Tenet Healthcare Corporation THC reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.44, which surpassed the Zacks Consensus Estimate by 17.4% and management’s expected range of $2.69-$3.
Earnings call transcript: Tenet Healthcare misses Q4 2024 revenue forecast
Tenet Healthcare Corporation (NYSE:THC) reported its fourth-quarter 2024 earnings, revealing a mixed performance that saw earnings per share (EPS) exceed expectations while revenue fell short. The company posted an EPS of $3.
Tenet Healthcare selloff overdone after Q4 earnings, says Cantor Fitzgerald
Tenet Healthcare (THC) reported Q4 earnings and guidance in line with estimates, but Cantor Fitzgerald tells investors in a research note that
Tenet Healthcare (NYSE:THC) Misses Q4 Revenue Estimates
Hospital operator Tenet Healthcare (NYSE:THC) in Q4 CY2024, with sales falling 5.7% year on year to $5.07 billion. The company’s full-year revenue guidance of $20.8 billion at the midpoint came in 2.4% below analysts’ estimates.
Tenet Healthcare Corporation (THC) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call February 12, 2025 10:00 AM ETCompany ParticipantsWill McDowell - Vice President
Tenet Healthcare reports Q4 adjusted EPS $3.44, consensus $2.83
Reports Q4 revenue $5.07B, consensus $5.17B. “2024 was an outstanding year for Tenet characterized by robust revenue growth, efficient
Tenet Healthcare beats Q4 estimates, shares rise
NEW YORK - On Wednesday, Tenet Healthcare Corporation (NYSE:THC) reported fourth quarter earnings that beat analyst expectations, sending shares up 1.91% in after-hours trading.
Breaking Down Tenet Healthcare: 8 Analysts Share Their Views
Across the recent three months, 8 analysts have shared their insights on Tenet Healthcare THC +1.68% Get Free Report , ...
Healthcare Dive7h
Tenet has ‘outstanding’ 2024, addresses policy changes in Washington
Health system leaders said Tenet is mostly insulated from proposed policy changes like Medicaid cuts due to its focus on ...
Fierce Healthcare1d
Tenet Healthcare CEO touts portfolio transformation, policy change bulwarks on Q4 earnings call
Tenet Healthcare beat on earnings but landed well short on revenue expectations for the fourth quarter of 2024, fueling a ...
Modern Healthcare1d
Tenet doubles down on ambulatory surgery for long-term growth
Tenet added nearly 70 new and acquired ambulatory surgery centers last year through United Surgical Partners International.
Tenet Healthcare price target lowered to $161 from $190 at Barclays
Barclays lowered the firm’s price target on Tenet Healthcare (THC) to $161 from $190 and keeps an Overweight rating on the shares post the Q4 ...
Becker's Hospital Review1d
Tenet has 'outstanding' 2024 with $6B operating income, 28.9% margin
Tenet Healthcare reported an operating income of $6 billion (28.8% margin) for the year ended Dec. 31, 2024, up from $2.5 billion (12.2% margin) in 2023.
Tenet Healthcare projects 7% adjusted EBITDA growth in 2025 with focus on ambulatory expansion
Q4 2024 Management View CEO Saumya Sutaria highlighted 2024 performance as "outstanding," driven by same-store revenue growth and disciplined operations. Full-year adjusted EBITDA reached $4 billion, ...